Garner Biosolutions

Executive Summary

Garner Biosolutions is a privately held biospecimen procurement company headquartered in Cambridge, Massachusetts, founded in 2017. The company specializes in ethically sourcing and supplying high-quality human biological materials—such as plasma and serum—for research, medical, and educational applications. By connecting researchers with a global network of pre-vetted collection sites, Garner emphasizes traceability, diverse population representation, and compliance with international regulatory standards. While the biospecimen market is fragmented, Garner's focus on quality and ethical sourcing positions it as a reliable intermediary for academia and biopharma. The company operates in a stable, non-cyclical niche but faces competition from larger distributors and in-house collection programs. Its private status and lack of disclosed funding or valuation suggest a conservative growth profile, with limited near-term inflection points. Overall, Garner Biosolutions represents a steady, low-risk service provider rather than a high-growth opportunity.

Upcoming Catalysts (preview)

• TBDStrategic partnership with a major pharma company for exclusive sample access20% success
• Q3 2026Expansion into new biomarker discovery services or liquid biopsy sample collection25% success
• TBDAdoption of new regulatory guidelines increasing demand for traceable biospecimens35% success